Showing results (91-100 of 136) with videos related to

Sort By:
Pageof 14
International Journal of Cancer|September 26, 2022
Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real-world databaseAudrey Mailliez, Veronique D'Hondt, Amelie Lusque, et al.
JAMA|June 7, 2011
Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndromeValérie Bonadona, Bernard Bonaïti, Sylviane Olschwang, et al.
Breast Cancer Research : BCR|July 6, 2012
Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO)Julie Lecarpentier, Catherine Noguès, Emmanuelle Mouret-Fourme, et al.
Breast Cancer Research and Treatment|November 14, 2015
Mutation analysis of PALB2 gene in French breast cancer familiesFrancesca Damiola, Inès Schultz, Laure Barjhoux, et al.
Cells|June 24, 2022
Next-Generation Sequencing on Circulating Tumor DNA in Advanced Solid Cancer: Swiss Army Knife for the Molecular Tumor Board? A Review of the Literature Focused on FDA Approved TestDamien Vasseur, Hela Sassi, Arnaud Bayle, et al.
European Journal of Human Genetics : EJHG|January 21, 2016
Mutation screening of MIR146A/B and BRCA1/2 3'-UTRs in the GENESIS studyAmandine I Garcia, Monique Buisson, Francesca Damiola, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 24, 2015
Breast Cancer Risk Associated with Estrogen Exposure and Truncating Mutation Location in BRCA1/2 CarriersJulie Lecarpentier, Catherine Noguès, Emmanuelle Mouret-Fourme, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 18, 2020
High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni SyndromeLaura Mezquita, Maria Jové, Ernest Nadal, et al.
Journal of Medical Genetics|October 27, 2017
Contribution of de novo and mosaic TP53 mutations to Li-Fraumeni syndromeMariette Renaux-Petel, Françoise Charbonnier, Jean-Christophe Théry, et al.
Human Mutation|December 9, 2021
Novel germline MET pathogenic variants in French patients with papillary renal cell carcinomas type IMolka Sebai, David Tulasne, Sandrine M Caputo, et al.
Pageof 14